These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 8012274)
1. 13-cis-retinoic acid-mediated growth inhibition of DU-145 human prostate cancer cells. Dahiya R; Boyle B; Park HD; Kurhanewicz J; Macdonald JM; Narayan P Biochem Mol Biol Int; 1994 Jan; 32(1):1-12. PubMed ID: 8012274 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Dahiya R; Park HD; Cusick J; Vessella RL; Fournier G; Narayan P Int J Cancer; 1994 Oct; 59(1):126-32. PubMed ID: 7523313 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of saturated fatty acid and upregulation of unsaturated fatty acid by 13-cis-retinoic acid in human prostate cancer cells. Dahiya R; Park HD; Cassafer G; Cusick J; Narayan P Biochem Int; 1992 Dec; 28(6):981-7. PubMed ID: 1290470 [TBL] [Abstract][Full Text] [Related]
4. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905 [TBL] [Abstract][Full Text] [Related]
5. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells. Waghray A; Webber MM Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041 [TBL] [Abstract][Full Text] [Related]
6. Regression of LNCaP human prostate tumor xenografts in athymic nude mice by 13-cis-retinoic acid and androgen ablation. Dahiya R; Zhang DY; Ho RJ; Haughney PC; Hayward SW; Cunha GR; Narayan P Biochem Mol Biol Int; 1995 Mar; 35(3):487-98. PubMed ID: 7773185 [TBL] [Abstract][Full Text] [Related]
7. Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis. Pili R; Kruszewski MP; Hager BW; Lantz J; Carducci MA Cancer Res; 2001 Feb; 61(4):1477-85. PubMed ID: 11245454 [TBL] [Abstract][Full Text] [Related]
8. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Webber MM; Waghray A Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042 [TBL] [Abstract][Full Text] [Related]
9. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Siu SW; Lau KW; Tam PC; Shiu SY Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702 [TBL] [Abstract][Full Text] [Related]
10. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938 [TBL] [Abstract][Full Text] [Related]
12. Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity. Stearns ME; Wang M; Fudge K Cancer Res; 1993 Jul; 53(13):3073-7. PubMed ID: 8319215 [TBL] [Abstract][Full Text] [Related]
13. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related]
14. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability. Avis I; Mathias A; Unsworth EJ; Miller MJ; Cuttitta F; Mulshine JL; Jakowlew SB Cell Growth Differ; 1995 May; 6(5):485-92. PubMed ID: 7647031 [TBL] [Abstract][Full Text] [Related]
15. Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors. Wang DL; Marko M; Dahl AR; Engelke KS; Placke ME; Imondi AR; Mulshine JL; De Luca LM Clin Cancer Res; 2000 Sep; 6(9):3636-45. PubMed ID: 10999756 [TBL] [Abstract][Full Text] [Related]
16. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice. Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a. Berg WJ; Nanus DM; Leung A; Brown KT; Hutchinson B; Mazumdar M; Xu XC; Lotan R; Reuter VE; Motzer RJ Clin Cancer Res; 1999 Jul; 5(7):1671-5. PubMed ID: 10430067 [TBL] [Abstract][Full Text] [Related]
18. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270 [TBL] [Abstract][Full Text] [Related]
19. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells. Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894 [TBL] [Abstract][Full Text] [Related]
20. Induction of matrix metalloprotease-1 gene expression by retinoic acid in the human pancreatic tumour cell line Dan-G. von Marschall Z; Riecken EO; Rosewicz S Br J Cancer; 1999 Jun; 80(7):935-9. PubMed ID: 10362099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]